| Overview |
| bsm-54451r-apc-cy5.5 |
| Fbx32 Recombinant Antibody, APC-Cy5.5 Conjugated |
| WB |
| Mouse, Rat |
| Human |
| Specifications |
| APC-Cy5.5 |
| Rabbit |
| Recombinant human Fbx32 |
| 1-200/355 |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 114907 |
| Q969P5 |
| Cytoplasm, Nucleus |
| Fbx32; 4833442G10Rik; AI430017; Atrogin 1; Atrogin-1; ATROGIN1; Atrophy gene 1; F box only protein 32; F-box only protein 32; F-box protein 32; FBX32_HUMAN; fbxo25; FBXO32; FLJ32424; MAFbx; MGC108443; MGC137646; MGC33610; Muscle atrophy F box; Muscle atrophy F box protein; Muscle atrophy F-box protein. |
| Substrate recognition component of a (SKP1-CUL1-F-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Probably recognizes and binds to phosphorylated target proteins during skeletal muscle atrophy. Recognizes TERF1. |
| Application Dilution |
| WB |
1:1000-2000 |
Powered by Bioz